|
1.
|
Puxeddu E and Filetti S: The 2009 American
Thyroid Association Guidelines for Management of Thyroid Nodules
and Differentiated Thyroid Cancer: progress on the road from
consensus- to evidence-based practice. Thyroid. 19:1145–1147. 2009.
View Article : Google Scholar
|
|
2.
|
Shook D and Keller R: Mechanisms,
mechanics and function of epithelial-mesenchymal transitions in
early development. Mech Dev. 120:1351–1383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Takeichi M: Cadherin cell adhesion
receptors as a morphogenetic regulator. Science. 251:1451–1455.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Matteucci E, Ridolfi E and Desiderio MA:
Hepatocyte growth factor differently influences Met-E-cadherin
phosphorylation and downstream signaling pathway in two models of
breast cells. Cell Mol Life Sci. 63:2016–2026. 2006. View Article : Google Scholar
|
|
6.
|
Wang H, Radjendirane V, Wary KK and
Chakrabarty S: Transforming growth factor beta regulates cell-cell
adhesion through extracellular matrix remodeling and activation of
focal adhesion kinase in human colon carcinoma Moser cells.
Oncogene. 23:5558–5561. 2004. View Article : Google Scholar
|
|
7.
|
Honma N, Genda T, Matsuda Y, Yamagiwa S,
Takamura M, Ichida T and Aoyagi Y: MEK/ERK signaling is a critical
mediator for integrin-induced cell scattering in highly metastatic
hepatocellular carcinoma cells. Lab Invest. 86:687–696. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Corn PG, Smith BD, Ruckdeschel ES, Douglas
D, Baylin SB and Herman JG: E-cadherin expression is silenced by 5′
CpG island methylation in acute leukemia. Clin Cancer Res.
6:4243–4248. 2000.
|
|
9.
|
Gagnon J, Shaker S, Primeau M, Hurtubise A
and Momparler RL: Interaction of 5-aza-2′-deoxycytidine and
depsipeptide on anti-neoplastic activity and activation of
14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3
expression in human breast carcinoma cells. Anticancer Drugs.
14:193–202. 2003.
|
|
10.
|
Lind GE, Thorstensen L, Lovig T, Meling
GI, Hamelin R, Rognum TO, Esteller M and Lothe RA: A CpG island
hypermethylation profile of primary colorectal carcinomas and colon
cancer cell lines. Mol Cancer. 3:282004. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Jaggi M, Rao PS, Smith DJ, Wheelock MJ,
Johnson KR, Hemstreet GP and Balaji KC: E-cadherin phosphorylation
by protein kinase D1/protein kinase C{mu} is associated with
altered cellular aggregation and motility in prostate cancer.
Cancer Res. 65:483–492. 2005.PubMed/NCBI
|
|
12.
|
Le TL, Joseph SR, Yap AS and Stow JL:
Protein kinase C regulates endocytosis and recycling of E-cadherin.
Am J Physiol Cell Physiol. 283:C489–C499. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Takahashi E, Nagano O, Ishimoto T, Yae T,
Suzuki Y, Shinoda T, Nakamura S, Niwa S, Ikeda S, Koga H, Tanihara
H and Saya H: TNF-{alpha} regulates TGF-{beta}-dependent
epithelial-mesenchymal transition by promoting
hyaluronan-CD44-Moesin interaction. J Biol Chem. 285:4060–4073.
2010.
|
|
14.
|
Fluge O, Bruland O, Akslen LA, Lillehaug
JR and Varhaug JE: Gene expression in poorly differentiated
papillary thyroid carcinomas. Thyroid. 16:161–175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Choi YL, Kim MK, Suh JW, Han J, Kim JH,
Yang JH and Nam SJ: Immunoexpression of HBME-1, high molecular
weight cytokeratin, cytokeratin 19, thyroid transcription factor-1,
and E-cadherin in thyroid carcinomas. J Korean Med Sci. 20:853–859.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Graff JR, Greenberg VE, Herman JG, Westra
WH, Boghaert ER, Ain KB, Saji M, Zeiger MA, Zimmer SG and Baylin
SB: Distinct patterns of E-cadherin CpG island methylation in
papillary, follicular, Hurthle's cell, and poorly differentiated
human thyroid carcinoma. Cancer Res. 58:2063–2066. 1998.PubMed/NCBI
|
|
17.
|
Hoque MO, Rosenbaum E, Westra WH, Xing M,
Ladenson P, Zeiger MA, Sidransky D and Umbricht CB: Quantitative
assessment of promoter methylation profiles in thyroid neoplasms. J
Clin Endocrinol Metab. 90:4011–4018. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Vasko V, Espinosa AV, Scouten W, He H,
Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la
Chapelle A, Saji M and Ringel MD: Gene expression and functional
evidence of epithelial-to-mesenchymal transition in papillary
thyroid carcinoma invasion. Proc Natl Acad Sci USA. 104:2803–2808.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Brecelj E, Frkovic Grazio S, Auersperg M
and Bracko M: Prognostic value of E-cadherin expression in thyroid
follicular carcinoma. Eur J Surg Oncol. 31:544–548. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Rocha AS, Soares P, Fonseca E,
Cameselle-Teijeiro J, Oliveira MC and Sobrinho-Simoes M: E-cadherin
loss rather than beta-catenin alterations is a common feature of
poorly differentiated thyroid carcinomas. Histopathology.
42:580–587. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Graff JR, Gabrielson E, Fujii H, Baylin SB
and Herman JG: Methylation patterns of the E-cadherin 5′ CpG island
are unstable and reflect the dynamic, heterogeneous loss of
E-cadherin expression during metastatic progression. J Biol Chem.
275:2727–2732. 2000.
|
|
22.
|
Gupta A, Deshpande CG and Badve S: Role of
E-cadherins in development of lymphatic tumor emboli. Cancer.
97:2341–2347. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Batistatou A, Charalabopoulos AK, Scopa
CD, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ and
Charalabopoulos K: Expression patterns of dysadherin and E-cadherin
in lymph node metastases of colorectal carcinoma. Virchows Arch.
448:763–767. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Friedl P, Noble PB, Walton PA, Laird DW,
Chauvin PJ, Tabah RJ, Black M and Zanker KS: Migration of
coordinated cell clusters in mesenchymal and epithelial cancer
explants in vitro. Cancer Res. 55:4557–4560. 1995.PubMed/NCBI
|
|
25.
|
Nabeshima K, Moriyama T, Asada Y, Komada
N, Inoue T, Kataoka H, Sumiyoshi A and Koono M: Ultrastructural
study of TPA-induced cell motility: human well-differentiated
rectal adenocarcinoma cells move as coherent sheets via localized
modulation of cell-cell adhesion. Clin Exp Metastasis. 13:499–508.
1995. View Article : Google Scholar
|
|
26.
|
Brandt B, Junker R, Griwatz C, Heidl S,
Brinkmann O, Semjonow A, Assmann G and Zanker KS: Isolation of
prostate-derived single cells and cell clusters from human
peripheral blood. Cancer Res. 56:4556–4561. 1996.PubMed/NCBI
|
